Diabetologia

How the immunoassay transformed C-peptide from a duckling into a swan

J. Roth, I. Whitford, R. Dankner, A. L. Szulc

Congenital anomalies in diabetic pregnancy: an important confirmation

D. R. Hadden

Is FTO a type 2 diabetes susceptibility gene?

D. Meyre

Deploying insulin granule–granule fusion to rescue deficient insulin secretion in diabetes

H. Y. Gaisano

Complement C3: an emerging risk factor in cardiometabolic disease

E. Hertle, M. M. J. van Greevenbroek, C. D. A. Stehouwer

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

G. Musso, M. Cassader, F. Rosina, R. Gambino

The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes

J. D. Krebs, C. R. Elley, A. Parry-Strong, H. Lunt, P. L. Drury, D. A. Bell, E. Robinson, S. A. Moyes, J. I. Mann

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study

B. Eliasson, D. Möller-Goede, K. Eeg-Olofsson, C. Wilson, J. Cederholm, P. Fleck, M. Diamant, M.-R. Taskinen, U. Smith

Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety

D. Nathanson, B. Ullman, U. Löfström, A. Hedman, M. Frick, Å. Sjöholm, T. Nyström

Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study

R. Bell, S. V. Glinianaia, P. W. G. Tennant, R. W. Bilous, J. Rankin

Cancer occurrence in Danish diabetic patients: duration and insulin effects

B. Carstensen, D. R. Witte, S. Friis

Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting

L. J. Gray, M. J. Davies, S. Hiles, N. A. Taub, D. R. Webb, B. T. Srinivasan, K. Khunti

The association between prior infection with five serotypes of Coxsackievirus B and incident type 2 diabetes mellitus in the EPIC-Norfolk study

E. Gkrania-Klotsas, C. Langenberg, S. Tauriainen, S. J. Sharp, R. Luben, N. G. Forouhi, K. T. Khaw, H. Hyöty, N. J. Wareham

Impact of maternal diabetes on birthweight is greater in non-Hispanic blacks than in non-Hispanic whites

K. J. Hunt, N. M. Marlow, M. Gebregziabher, C. N. Ellerbe, J. Mauldin, M. E. Mayorga, J. E. Korte

Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians

H. Li, T. O. Kilpeläinen, C. Liu, J. Zhu, Y. Liu, C. Hu, Z. Yang, W. Zhang, W. Bao, S. Cha, Y. Wu, T. Yang, A. Sekine, B. Y. Choi, C. S. Yajnik, D. Zhou, F. Takeuchi, K. Yamamoto, J. C. Chan, K. R. Mani, L. F. Been, M. Imamura, E. Nakashima, N. Lee, T. Fujisawa, S. Karasawa, W. Wen, C. V. Joglekar, W. Lu, Y. Chang, Y. Xiang, Y. Gao, S. Liu, Y. Song, S. H. Kwak, H. D. Shin, K. S. Park, C. H. D. Fall, J. Y. Kim, P. C. Sham, K. S. L. Lam, W. Zheng, X. Shu, H. Deng, H. Ikegami, G. V. Krishnaveni, D. K. Sanghera, L. Chuang, L. Liu, R. Hu, Y. Kim, M. Daimon, K. Hotta, W. Jia, J. S. Kooner, J. C. Chambers, G. R. Chandak, R. C. Ma, S. Maeda, R. Dorajoo, M. Yokota, R. Takayanagi, N. Kato, X. Lin, R. J. F. Loos

Confirmation of novel type 1 diabetes risk loci in families

J. D. Cooper, J. M. M. Howson, D. Smyth, N. M. Walker, H. Stevens, J. H. M. Yang, J.-X. She, G. S. Eisenbarth, M. Rewers, J. A. Todd, B. Akolkar, P. Concannon, H. A. Erlich, C. Julier, G. Morahan, J. Nerup, C. Nierras, F. Pociot, S. S. Rich

Multivesicular exocytosis in rat pancreatic beta cells

M. B. Hoppa, E. Jones, J. Karanauskaite, R. Ramracheya, M. Braun, S. C. Collins, Q. Zhang, A. Clark, L. Eliasson, C. Genoud, P. E. MacDonald, A. G. Monteith, S. Barg, J. Galvanovskis, P. Rorsman

Novel standards in the measurement of rat insulin granules combining electron microscopy, high-content image analysis and in silico modelling

E. Fava, J. Dehghany, J. Ouwendijk, A. Müller, A. Niederlein, P. Verkade, M. Meyer-Hermann, M. Solimena

Hedgehog signals inhibit postnatal beta cell neogenesis from adult rat exocrine pancreas in vitro

J. K. Mfopou, L. Baeyens, L. Bouwens

Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide

Y. J. Park, S. Lee, T. J. Kieffer, G. L. Warnock, N. Safikhan, M. Speck, Z. Hao, M. Woo, L. Marzban

Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death

E. Reich, A. Tamary, R. Vogt Sionov, D. Melloul

The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways

E. Favaro, R. Granata, I. Miceli, A. Baragli, F. Settanni, P. Cavallo Perin, E. Ghigo, G. Camussi, M. M. Zanone

Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat

M. Futamura, J. Yao, X. Li, R. Bergeron, J.-L. Tran, E. Zycband, J. Woods, Y. Zhu, Q. Shao, H. Maruki-Uchida, H. Goto-Shimazaki, R. B. Langdon, M. D. Erion, J. Eiki, Y.-P. Zhou

Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes

Z.-l. Zhi, A. Kerby, A. J. F. King, P. M. Jones, J. C. Pickup

Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice

D. M. Xu, X. F. Yu, D. Zhang, M. X. Zhang, J. F. Zhou, P. H. Tan, Y. C. Ding

A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3

K. Hess, S. H. Alzahrani, M. Mathai, V. Schroeder, A. M. Carter, G. Howell, T. Koko, M. W. J. Strachan, J. F. Price, K. A. Smith, P. J. Grant, R. A. Ajjan

The proteomic signature of insulin-resistant human skeletal muscle reveals increased glycolytic and decreased mitochondrial enzymes

J. Giebelstein, G. Poschmann, K. Højlund, W. Schechinger, J. W. Dietrich, K. Levin, H. Beck-Nielsen, K. Podwojski, K. Stühler, H. E. Meyer, H. H. Klein

Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways

S. Lambernd, A. Taube, A. Schober, B. Platzbecker, S. W. Görgens, R. Schlich, K. Jeruschke, J. Weiss, K. Eckardt, J. Eckel

Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans

B. C. Bergman, D. M. Hunerdosse, A. Kerege, M. C. Playdon, L. Perreault

Is diabetes an acquired disorder of reactive glucose metabolites and their intermediates?

T. Fleming, J. Cuny, G. Nawroth, Z. Djuric, P. M. Humpert, M. Zeier, A. Bierhaus, P. P. Nawroth

Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes

M. Ståhlman, H. T. Pham, M. Adiels, T. W. Mitchell, S. J. Blanksby, B. Fagerberg, K. Ekroos, J. Borén

Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance

M. Maris, L. Overbergh, C. Gysemans, A. Waget, A. K. Cardozo, E. Verdrengh, J. P. M. Cunha, T. Gotoh, M. Cnop, D. L. Eizirik, R. Burcelin, C. Mathieu

Visual sensitivity loss in the central 30° of visual field is associated with diabetic peripheral neuropathy

G. P. Sampson, A. M. Shahidi, D. Vagenas, N. Pritchard, K. Edwards, A. W. Russell, R. A. Malik, N. Efron

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

A. J. Varewijck, J. A. M. J. L. Janssen, M. Vähätalo, L. J. Hofland, S. W. J. Lamberts, H. Yki-Järvinen

Mice expressing a human KATP channel mutation have altered channel ATP sensitivity but no cardiac abnormalities

R. Clark, R. Männikkö, D. J. Stuckey, M. Iberl, K. Clarke, F. M. Ashcroft

Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes

D. K. Kim, B. Y. Nam, J. J. Li, J. T. Park, S. H. Lee, D. H. Kim, J. Y. Kim, H. Y. Kang, S. H. Han, T. H. Yoo, D. S. Han, S. W. Kang

Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions

E. van Duinkerken, M. M. Schoonheim, R. G. IJzerman, M. Klein, C. M. Ryan, A. C. Moll, F. J. Snoek, F. Barkhof, M. Diamant, P. J. W. Pouwels

Oral glucose tolerance test in patients with undiagnosed diabetes and coronary artery disease: When should it be performed?

A. Kollias, E. Diamanti-Kandarakis

Erratum to: Cancer occurrence in Danish diabetic patients: duration and insulin effects

B. Carstensen, D. R. Witte, S. Friis

LIST OF REFEREES